HYPERCHOLESTEROLEMIA

作品数：101被引量：227H指数：8
导出分析报告
相关领域：医药卫生更多>>
相关作者：秦玉刘云付卿卿陈欣杰徐向华更多>>
相关机构：中国福利会国际和平妇幼保健院第三军医大学首都医科大学中国南方航空股份有限公司更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划北京市自然科学基金湖北省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Journal of Geriatric Cardiologyx
共 条 记 录，以下是1-5
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Characterization of coronary atherosclerotic plaques in a homozygous familial hypercholesterolemia visualized by optical coherence tomography
《Journal of Geriatric Cardiology》2018年第12期738-743,共6页Ze-Sen LIU Jie PENG Shi-Long WANG Tao JIANG Jie LIN Kang MENG 
the National Natural Science Foundation of China(No.81370443&No.81170793).
Familial hypercholesterolemia(FH)is an autosomal dominant genetic disorder,which resulted in severe elevations in low-density lipoprotein cholesterol(LDL-C)and a markedly increased risk of early-onset coronary disease...
关键词：CORONARY ATHEROSCLEROTIC PLAQUES HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA Optical coherence tomography 
Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia被引量：3
《Journal of Geriatric Cardiology》2018年第6期434-440,共7页Xu WANG Long JIANG Li-Yuan SUN Yue WU Wen-Hui WEN Xi-Fu WANG Wei LIU Yu-Jie ZHOU Lu-Ya WANG 
We greatly appreciate the support of the patients and their families for participation in this study and cardiologists who participated in this study. This work was supported by grants from the National Natural Science Foundation of China （No. 30470722, 30771982 and 30772356） and the Beijing Natural Science Foundation （No. 7032012, 7052021 and No. 7062010）. The authors have no conflicts of interest to declare.
Background Familial hypercholesterolemia （FH） is an autosomal dominant disorder of lipoprotein metabolism which can lead to premature coronary heart disease （pCHD）. There are about 3.8 million potential FH patient...
关键词：Familial hypercholesterolemia Low-density lipoprotein receptor MUTATION 
The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years被引量：2
《Journal of Geriatric Cardiology》2011年第1期1-11,共11页Ori Ben-Yehuda Nanette K. Wenger Christian Constance Franklin Zieve Mary E. Hanson Jian-Xin Lin Arvind K. Shah Charlotte Jones-Burton Andrew M. Tershakovec 
Background Coronary heart disease （CHD） risk increases with age; yet lipid-lowering therapies are significantly under-utilized in patients 〉 65 years. The objective was to evaluate the safety and efficacy of lipid-...
关键词：cholesterol absorption inhibitor LDL-C HYPERCHOLESTEROLEMIA STATIN 
The distribution of 10-year cardiovascular risk in Chinese adults： analysis of the China Health Examination Database （CHED） 2008被引量：1
《Journal of Geriatric Cardiology》2010年第3期131-137,共7页Liu-Xin Wu Qiang Zen Dong-Chang Qiang 
Objective Global cardiovascular risk assessment has been incorporated into current Chinese guidelines for the management of hypertension and hypercholesterolemia. The aim of our study is to determine the distribution ...
关键词：cardiovascular disease HYPERTENSION HYPERCHOLESTEROLEMIA PREVENTION Chinese 
Effects of simvastatin on lipid levels and platelet activation in elderly patients with hypercholesterolemia被引量：1
《Journal of Geriatric Cardiology》2007年第4期215-217,共3页Zhe Chen Yuanping Hou Miaobin Liu 
Background and Objective To investigate the effects of simvastatin on lipid lowering therapy and platelet activation in elderly patients with hypercholesterolemia. Methods Fasting serum lipids, CD63, CD41a, serum gluc...
关键词：SIMVASTATIN PLATELET ACTIVITY HYPERCHOLESTEROLEMIA 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部